{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T17:39:49Z","timestamp":1793209189452,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T00:00:00Z","timestamp":1650067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T00:00:00Z","timestamp":1650067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science, and Technology of Japan","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s00262-022-03200-w","type":"journal-article","created":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T11:11:21Z","timestamp":1650107481000},"page":"2765-2776","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Role of the cGAS-STING pathway in regulating the tumor-immune microenvironment in dMMR\/MSI colorectal cancer"],"prefix":"10.1007","volume":"71","author":[{"given":"Akinao","family":"Kaneta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9339-3792","authenticated-orcid":false,"given":"Shotaro","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Okayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuro","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuharu","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisei","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misato","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosaku","family":"Mimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Kanke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motonobu","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zenichiro","family":"Saze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shotaro","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Onozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Momma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Ohki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Kono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,16]]},"reference":[{"key":"3200_CR1","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3322\/caac.21601","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Goding Sauer A, Fedewa SA, Butterly LF, Anderson JC, Cercek A, Smith RA, Jemal A (2020) Colorectal cancer statistics, 2020. CA Cancer J Clin 70:145\u2013164. https:\/\/doi.org\/10.3322\/caac.21601","journal-title":"CA Cancer J Clin"},{"key":"3200_CR2","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/s41575-019-0189-8","volume":"16","author":"N Keum","year":"2019","unstructured":"Keum N, Giovannucci E (2019) Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Rev Gastroenterol Hepatol 16:713\u2013732. https:\/\/doi.org\/10.1038\/s41575-019-0189-8","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3200_CR3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41392-020-0116-z","volume":"5","author":"YH Xie","year":"2020","unstructured":"Xie YH, Chen YX, Fang JY (2020) Comprehensive review of targeted therapy for colorectal cancer. Signal Transduct Target Ther 5:22. https:\/\/doi.org\/10.1038\/s41392-020-0116-z","journal-title":"Signal Transduct Target Ther"},{"key":"3200_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1897-4287-11-9","volume":"11","author":"K Tutlewska","year":"2013","unstructured":"Tutlewska K, Lubinski J, Kurzawski G (2013) Germline deletions in the EPCAM gene as a cause of Lynch syndrome - literature review. Hered Cancer Clin Pract 11:9. https:\/\/doi.org\/10.1186\/1897-4287-11-9","journal-title":"Hered Cancer Clin Pract"},{"key":"3200_CR5","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/humu.21446","volume":"32","author":"RP Kuiper","year":"2011","unstructured":"Kuiper RP, Vissers LE, Venkatachalam R et al (2011) Recurrence and variability of germline EPCAM deletions in Lynch syndrome. Hum Mutat 32:407\u2013414. https:\/\/doi.org\/10.1002\/humu.21446","journal-title":"Hum Mutat"},{"key":"3200_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13112638","author":"V Amodio","year":"2021","unstructured":"Amodio V, Mauri G, Reilly NM, Sartore-Bianchi A, Siena S, Bardelli A, Germano G (2021) Mechanisms of immune escape and resistance to checkpoint inhibitor therapies in mismatch repair deficient metastatic colorectal cancers. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13112638","journal-title":"Cancers (Basel)"},{"key":"3200_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13123063","author":"V Randrian","year":"2021","unstructured":"Randrian V, Evrard C, Tougeron D (2021) Microsatellite instability in colorectal cancers: carcinogenesis, neo-antigens immuno-resistance and emerging therapies. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13123063","journal-title":"Cancers (Basel)"},{"key":"3200_CR8","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1053\/j.gastro.2009.12.064","volume":"138","author":"CR Boland","year":"2010","unstructured":"Boland CR, Goel A (2010) Microsatellite instability in colorectal cancer. Gastroenterology 138:2073-2087.e2073. https:\/\/doi.org\/10.1053\/j.gastro.2009.12.064","journal-title":"Gastroenterology"},{"key":"3200_CR9","doi-asserted-by":"publisher","first-page":"3319","DOI":"10.3390\/cancers12113319","volume":"12","author":"M Deshpande","year":"2020","unstructured":"Deshpande M, Romanski PA, Rosenwaks Z, Gerhardt J (2020) Gynecological cancers caused by deficient mismatch repair and microsatellite instability. Cancers (Basel) 12:3319. https:\/\/doi.org\/10.3390\/cancers12113319","journal-title":"Cancers (Basel)"},{"key":"3200_CR10","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1136\/gut.2009.206250","volume":"60","author":"CC Pritchard","year":"2011","unstructured":"Pritchard CC, Grady WM (2011) Colorectal cancer molecular biology moves into clinical practice. Gut 60:116\u2013129. https:\/\/doi.org\/10.1136\/gut.2009.206250","journal-title":"Gut"},{"key":"3200_CR11","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/bjs.4472","volume":"91","author":"SM Phillips","year":"2004","unstructured":"Phillips SM, Banerjea A, Feakins R, Li SR, Bustin SA, Dorudi S (2004) Tumour-infiltrating lymphocytes in colorectal cancer with microsatellite instability are activated and cytotoxic. Br J Surg 91:469\u2013475. https:\/\/doi.org\/10.1002\/bjs.4472","journal-title":"Br J Surg"},{"key":"3200_CR12","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41575-019-0126-x","volume":"16","author":"K Ganesh","year":"2019","unstructured":"Ganesh K, Stadler ZK, Cercek A, Mendelsohn RB, Shia J, Segal NH, Diaz LA Jr (2019) Immunotherapy in colorectal cancer: rationale, challenges and potential. Nat Rev Gastroenterol Hepatol 16:361\u2013375. https:\/\/doi.org\/10.1038\/s41575-019-0126-x","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3200_CR13","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1126\/science.aan6733","volume":"357","author":"DT Le","year":"2017","unstructured":"Le DT, Durham JN, Smith KN et al (2017) Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science 357:409\u2013413. https:\/\/doi.org\/10.1126\/science.aan6733","journal-title":"Science"},{"key":"3200_CR14","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1126\/science.1229963","volume":"339","author":"J Wu","year":"2013","unstructured":"Wu J, Sun L, Chen X, Du F, Shi H, Chen C, Chen ZJ (2013) Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science 339:826\u2013830. https:\/\/doi.org\/10.1126\/science.1229963","journal-title":"Science"},{"key":"3200_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s43556-020-00006-z","author":"M Gao","year":"2020","unstructured":"Gao M, He Y, Tang H, Chen X, Liu S, Tao Y (2020) cGAS\/STING: novel perspectives of the classic pathway. Mol Biomed. https:\/\/doi.org\/10.1186\/s43556-020-00006-z","journal-title":"Mol Biomed"},{"key":"3200_CR16","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1084\/jem.20180139","volume":"215","author":"T Li","year":"2018","unstructured":"Li T, Chen ZJ (2018) The cGAS-cGAMP-STING pathway connects DNA damage to inflammation, senescence, and cancer. J Exp Med 215:1287\u20131299. https:\/\/doi.org\/10.1084\/jem.20180139","journal-title":"J Exp Med"},{"key":"3200_CR17","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13045-020-00916-z","volume":"13","author":"M Jiang","year":"2020","unstructured":"Jiang M, Chen P, Wang L et al (2020) cGAS-STING, an important pathway in cancer immunotherapy. J Hematol Oncol 13:81. https:\/\/doi.org\/10.1186\/s13045-020-00916-z","journal-title":"J Hematol Oncol"},{"key":"3200_CR18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ctrv.2017.11.007","volume":"63","author":"R Tokunaga","year":"2018","unstructured":"Tokunaga R, Zhang W, Naseem M, Puccini A, Berger MD, Soni S, McSkane M, Baba H, Lenz H-J (2018) CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation\u2013a target for novel cancer therapy. Cancer Treat Rev 63:40\u201347. https:\/\/doi.org\/10.1016\/j.ctrv.2017.11.007","journal-title":"Cancer Treat Rev"},{"key":"3200_CR19","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00005-017-0481-7","volume":"66","author":"O Sokolowska","year":"2018","unstructured":"Sokolowska O, Nowis D (2018) STING signaling in cancer cells: Important or not? Arch Immunol Ther Exp (Warsz) 66:125\u2013132. https:\/\/doi.org\/10.1007\/s00005-017-0481-7","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"3200_CR20","doi-asserted-by":"publisher","first-page":"39858","DOI":"10.1038\/srep39858","volume":"7","author":"S Song","year":"2017","unstructured":"Song S, Peng P, Tang Z et al (2017) Decreased expression of STING predicts poor prognosis in patients with gastric cancer. Sci Rep 7:39858. https:\/\/doi.org\/10.1038\/srep39858","journal-title":"Sci Rep"},{"key":"3200_CR21","doi-asserted-by":"publisher","first-page":"4932","DOI":"10.7150\/jca.32806","volume":"10","author":"HJ Chon","year":"2019","unstructured":"Chon HJ, Kim H, Noh JH et al (2019) STING signaling is a potential immunotherapeutic target in colorectal cancer. J Cancer 10:4932\u20134938. https:\/\/doi.org\/10.7150\/jca.32806","journal-title":"J Cancer"},{"key":"3200_CR22","doi-asserted-by":"publisher","first-page":"e0165681","DOI":"10.1371\/journal.pone.0165681","volume":"11","author":"Y Bu","year":"2016","unstructured":"Bu Y, Liu F, Jia Q-A, Yu S-N (2016) Decreased expression of TMEM173 predicts poor prognosis in patients with hepatocellular carcinoma. PLoS One 11:e0165681. https:\/\/doi.org\/10.1371\/journal.pone.0165681","journal-title":"PLoS One"},{"key":"3200_CR23","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.celrep.2015.12.029","volume":"14","author":"T Xia","year":"2016","unstructured":"Xia T, Konno H, Ahn J, Barber GN (2016) Deregulation of STING signaling in colorectal carcinoma constrains DNA damage responses and correlates with tumorigenesis. Cell Rep 14:282\u2013297. https:\/\/doi.org\/10.1016\/j.celrep.2015.12.029","journal-title":"Cell Rep"},{"key":"3200_CR24","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.cell.2018.08.027","volume":"174","author":"SF Bakhoum","year":"2018","unstructured":"Bakhoum SF, Cantley LC (2018) The multifaceted role of chromosomal instability in cancer and its microenvironment. Cell 174:1347\u20131360. https:\/\/doi.org\/10.1016\/j.cell.2018.08.027","journal-title":"Cell"},{"key":"3200_CR25","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.1200\/jco.2009.27.0652","volume":"28","author":"A de la Chapelle","year":"2010","unstructured":"de la Chapelle A, Hampel H (2010) Clinical relevance of microsatellite instability in colorectal cancer. J Clin Oncol 28:3380\u20133387. https:\/\/doi.org\/10.1200\/jco.2009.27.0652","journal-title":"J Clin Oncol"},{"key":"3200_CR26","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/nature24050","volume":"550","author":"Z Dou","year":"2017","unstructured":"Dou Z, Ghosh K, Vizioli MG et al (2017) Cytoplasmic chromatin triggers inflammation in senescence and cancer. Nature 550:402\u2013406. https:\/\/doi.org\/10.1038\/nature24050","journal-title":"Nature"},{"key":"3200_CR27","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.devcel.2017.05.022","volume":"41","author":"S Santaguida","year":"2017","unstructured":"Santaguida S, Richardson A, Iyer DR et al (2017) Chromosome mis-segregation generates cell-cycle-arrested cells with complex karyotypes that are eliminated by the immune system. Dev Cell 41:638-651.e635. https:\/\/doi.org\/10.1016\/j.devcel.2017.05.022","journal-title":"Dev Cell"},{"issue":"96\u2013108","key":"3200_CR28","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/j.ccell.2020.11.006","volume":"39","author":"C Lu","year":"2021","unstructured":"Lu C, Guan J, Lu S et al (2021) DNA sensing in mismatch repair-deficient tumor cells is essential for anti-tumor immunity. Cancer Cell 39(96\u2013108):e106. https:\/\/doi.org\/10.1016\/j.ccell.2020.11.006","journal-title":"Cancer Cell"},{"issue":"109\u2013121","key":"3200_CR29","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/j.ccell.2020.11.004","volume":"39","author":"J Guan","year":"2021","unstructured":"Guan J, Lu C, Jin Q et al (2021) MLH1 deficiency-triggered DNA hyperexcision by exonuclease 1 activates the cGAS-STING pathway. Cancer Cell 39(109\u2013121):e105. https:\/\/doi.org\/10.1016\/j.ccell.2020.11.004","journal-title":"Cancer Cell"},{"key":"3200_CR30","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20210108","author":"C Mowat","year":"2021","unstructured":"Mowat C, Mosley SR, Namdar A, Schiller D, Baker K (2021) Anti-tumor immunity in mismatch repair-deficient colorectal cancers requires type I IFN\u2013driven CCL5 and CXCL10. J Exp Med. https:\/\/doi.org\/10.1084\/jem.20210108","journal-title":"J Exp Med"},{"key":"3200_CR31","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2004088","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U et al (2013) Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. https:\/\/doi.org\/10.1126\/scisignal.2004088","journal-title":"Sci Signal"},{"key":"3200_CR32","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf8399","author":"T Davoli","year":"2017","unstructured":"Davoli T, Uno H, Wooten EC, Elledge SJ (2017) Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy. Science. https:\/\/doi.org\/10.1126\/science.aaf8399","journal-title":"Science"},{"key":"3200_CR33","doi-asserted-by":"publisher","first-page":"73971","DOI":"10.18632\/oncotarget.12605","volume":"7","author":"C Zhang","year":"2016","unstructured":"Zhang C, Li J, Wang H, Song SW (2016) Identification of a five B cell-associated gene prognostic and predictive signature for advanced glioma patients harboring immunosuppressive subtype preference. Oncotarget 7:73971\u201373983. https:\/\/doi.org\/10.18632\/oncotarget.12605","journal-title":"Oncotarget"},{"key":"3200_CR34","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1016\/s0140-6736(15)01281-7","volume":"387","author":"RS Herbst","year":"2016","unstructured":"Herbst RS, Baas P, Kim DW et al (2016) Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial. Lancet 387:1540\u20131550. https:\/\/doi.org\/10.1016\/s0140-6736(15)01281-7","journal-title":"Lancet"},{"key":"3200_CR35","doi-asserted-by":"publisher","first-page":"5977","DOI":"10.3892\/ol.2019.10953","volume":"18","author":"T Kikuchi","year":"2019","unstructured":"Kikuchi T, Mimura K, Okayama H et al (2019) A subset of patients with MSS\/MSI-low-colorectal cancer showed increased CD8(+) TILs together with up-regulated IFN-\u03b3. Oncol Lett 18:5977\u20135985. https:\/\/doi.org\/10.3892\/ol.2019.10953","journal-title":"Oncol Lett"},{"key":"3200_CR36","doi-asserted-by":"publisher","first-page":"4468","DOI":"10.1158\/1078-0432.ccr-17-3533","volume":"24","author":"M Noda","year":"2018","unstructured":"Noda M, Okayama H, Tachibana K et al (2018) glycosyltransferase gene expression identifies a poor prognostic colorectal cancer subtype associated with mismatch repair deficiency and incomplete glycan synthesis. Clin Cancer Res 24:4468\u20134481. https:\/\/doi.org\/10.1158\/1078-0432.ccr-17-3533","journal-title":"Clin Cancer Res"},{"key":"3200_CR37","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.molcel.2013.01.039","volume":"50","author":"T Abe","year":"2013","unstructured":"Abe T, Harashima A, Xia T, Konno H, Konno K, Morales A, Ahn J, Gutman D, Barber GN (2013) STING recognition of cytoplasmic DNA instigates cellular defense. Mol Cell 50:5\u201315. https:\/\/doi.org\/10.1016\/j.molcel.2013.01.039","journal-title":"Mol Cell"},{"key":"3200_CR38","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.18632\/oncotarget.3205","volume":"6","author":"TJ Zumwalt","year":"2015","unstructured":"Zumwalt TJ, Arnold M, Goel A, Boland CR (2015) Active secretion of CXCL10 and CCL5 from colorectal cancer microenvironments associates with GranzymeB+ CD8+ T-cell infiltration. Oncotarget 6:2981\u20132991. https:\/\/doi.org\/10.18632\/oncotarget.3205","journal-title":"Oncotarget"},{"key":"3200_CR39","doi-asserted-by":"publisher","first-page":"292376","DOI":"10.1155\/2014\/292376","volume":"2014","author":"D Aldinucci","year":"2014","unstructured":"Aldinucci D, Colombatti A (2014) The inflammatory chemokine CCL5 and cancer progression. Med Inflamm 2014:292376. https:\/\/doi.org\/10.1155\/2014\/292376","journal-title":"Med Inflamm"},{"key":"3200_CR40","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/08923973.2017.1417997","volume":"40","author":"L Yang","year":"2018","unstructured":"Yang L, Wang B, Qin J, Zhou H, Majumdar AP, Peng F (2018) Blockade of CCR5-mediated myeloid derived suppressor cell accumulation enhances anti-PD1 efficacy in gastric cancer. Immunopharmacol Immunotoxicol 40:91\u201397","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"3200_CR41","doi-asserted-by":"publisher","first-page":"660184","DOI":"10.3389\/fimmu.2021.660184","volume":"12","author":"WO Hemphill","year":"2021","unstructured":"Hemphill WO, Simpson SR, Liu M, Salsbury FR Jr, Hollis T, Grayson JM, Perrino FW (2021) TREX1 as a novel immunotherapeutic target. Front Immunol 12:660184. https:\/\/doi.org\/10.3389\/fimmu.2021.660184","journal-title":"Front Immunol"},{"key":"3200_CR42","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/ncb1038","volume":"5","author":"CA Sledz","year":"2003","unstructured":"Sledz CA, Holko M, de Veer MJ, Silverman RH, Williams BR (2003) Activation of the interferon system by short-interfering RNAs. Nat Cell Biol 5:834\u2013839. https:\/\/doi.org\/10.1038\/ncb1038","journal-title":"Nat Cell Biol"},{"key":"3200_CR43","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1038\/s41388-017-0120-0","volume":"37","author":"H Konno","year":"2018","unstructured":"Konno H, Yamauchi S, Berglund A, Putney RM, Mul\u00e9 JJ, Barber GN (2018) Suppression of STING signaling through epigenetic silencing and missense mutation impedes DNA damage mediated cytokine production. Oncogene 37:2037\u20132051. https:\/\/doi.org\/10.1038\/s41388-017-0120-0","journal-title":"Oncogene"},{"key":"3200_CR44","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature09907","volume":"472","author":"JW Schoggins","year":"2011","unstructured":"Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, Bieniasz P, Rice CM (2011) A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472:481\u2013485. https:\/\/doi.org\/10.1038\/nature09907","journal-title":"Nature"},{"key":"3200_CR45","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/imr.12765","volume":"290","author":"BA Flood","year":"2019","unstructured":"Flood BA, Higgs EF, Li S, Luke JJ, Gajewski TF (2019) STING pathway agonism as a cancer therapeutic. Immunol Rev 290:24\u201338. https:\/\/doi.org\/10.1111\/imr.12765","journal-title":"Immunol Rev"},{"key":"3200_CR46","doi-asserted-by":"publisher","first-page":"13597","DOI":"10.1038\/ncomms13597","volume":"7","author":"R Wilson","year":"2016","unstructured":"Wilson R, Espinosa-Diez C, Kanner N et al (2016) MicroRNA regulation of endothelial TREX1 reprograms the tumour microenvironment. Nat Commun 7:13597. https:\/\/doi.org\/10.1038\/ncomms13597","journal-title":"Nat Commun"},{"key":"3200_CR47","doi-asserted-by":"publisher","first-page":"15408","DOI":"10.1073\/pnas.1512832112","volume":"112","author":"O Demaria","year":"2015","unstructured":"Demaria O, De Gassart A, Coso S et al (2015) STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity. Proc Natl Acad Sci U S A 112:15408\u201315413. https:\/\/doi.org\/10.1073\/pnas.1512832112","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3200_CR48","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12943-019-1087-y","volume":"18","author":"Y Zhu","year":"2019","unstructured":"Zhu Y, An X, Zhang X, Qiao Y, Zheng T, Li X (2019) STING: a master regulator in the cancer-immunity cycle. Mol Cancer 18:152. https:\/\/doi.org\/10.1186\/s12943-019-1087-y","journal-title":"Mol Cancer"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-022-03200-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-022-03200-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-022-03200-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T11:11:47Z","timestamp":1664363507000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-022-03200-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,16]]},"references-count":48,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["3200"],"URL":"https:\/\/doi.org\/10.1007\/s00262-022-03200-w","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,16]]},"assertion":[{"value":"21 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No potential conflicts of interest relevant to this article were reported.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki and was approved by the Institutional Review Board of Fukushima Medical University (Fukushima, Japan). <i>Cell line authentication<\/i>: Human colorectal cancer cell lines were purchased from the Korean Cell Line Bank (SNU81) and the American Type Culture Collection (SW480), and the cell lines have been authenticated using STR analysis (Promega Japan, Tokyo, Japan).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}